Owners, management and financials
CVR: 27347282
Secondary names: CAREFARM A/S
Previous names: CAREFARM A/S
EUR 1,478,000
Gross profit
Net result: EUR 51,761,000
Orifarm Holding A/S (100%)
CVR · view owners
Mads Fink Eriksen, Thomas Brandhof
Board: Hans Carl Bøgh-Sørensen (chair) and 12 members
CVR · view management
Active
Founded 12 September 2003
CVR · view overview
62 employees
CVR · 2018
Owner registered: Orifarm Holding A/S
CVR · 08/04/2025
View the full event history
ORIFARM GROUP A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The company was previously named CAREFARM A/S. The management consists of Mads Fink Eriksen and Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Ole Michael Friis, Adeel Ahmad and Bettina Britt Juel Hansen. The company is owned by Orifarm Holding A/S. The company has 62 employees (2018). In 2025, the company reported a gross profit of EUR 1,478,000 and a net result of EUR 51,761,000 compared with EUR 3,260,000 the year before. Equity in the 2025 report amounted to EUR 413,677,000.
Source: annual report 2025, Danish Business Authority
ORIFARM GROUP A/S demonstrates strong financial health, highlighted by a significant profit of €51.76 million in 2025, despite revenue figures being unavailable for that year. Revenue has shown a steady upward trend, increasing from €1.36 million in 2021 to €3.79 million in 2024, while gross profit margins have remained robust, particularly in 2023 with €12.84 million. The company's equity position has also improved markedly, rising to €413.68 million in 2025 from €169.53 million in 2021, indicating a solid foundation for future growth. However, the fluctuating gross profit figures raise concerns about operational efficiency, warranting close monitoring as the company continues to expand within its industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at besidde kapitalandele i datterselskaber og drive handelsvirksomhed. Endvidere er selskabets formål at forestå forretningsudvikling, ledelsesmæssige opgaver samt administrative opgaver for koncernforbundne selskaber, herunder moder-, søster- og datterselskaber samt dertil beslægtede opgaver, der måtte forekomme i koncernen.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 0 EUR | 51.8 mio. EUR | 996 mio. EUR | 413.7 mio. EUR | 2212 | |
| 202401/01/2024 – 31/12/2024 | 3.8 mio. EUR | 3.3 mio. EUR | 1.1 mia. EUR | 374.2 mio. EUR | 202 | |
| 202301/01/2023 – 31/12/2023 | 3.7 mio. EUR | 22.4 mio. EUR | 1.1 mia. EUR | 208.1 mio. EUR | 2244 | |
| 202201/01/2022 – 31/12/2022 | 3.4 mio. EUR | 27.4 mio. EUR | 1 mia. EUR | 188.9 mio. EUR | 2136 | |
| 202101/01/2021 – 31/12/2021 | 1.4 mio. EUR | 28.7 mio. EUR | 855.5 mio. EUR | 169.5 mio. EUR | 1955 | |
| 202001/01/2020 – 31/12/2020 | 8.6 mio. EUR | 25.5 mio. EUR | 353.1 mio. EUR | 149 mio. EUR | 1177 | |
| 201901/01/2019 – 31/12/2019 | 13.9 mio. EUR | 34.7 mio. EUR | 272.1 mio. EUR | 167.9 mio. EUR | 1111 | |
| 201801/01/2018 – 31/12/2018 | 10 mio. EUR | 26.5 mio. EUR | 197.7 mio. EUR | 136 mio. EUR | 1036 | |
| 201701/01/2017 – 31/12/2017 | 8.6 mio. EUR | 21.9 mio. EUR | 172.4 mio. EUR | 117 mio. EUR | 797 | |
| 201601/01/2016 – 31/12/2016 | 8.8 mio. EUR | 10.2 mio. EUR | 180.8 mio. EUR | 98.5 mio. EUR | 960 | |
| 201501/01/2015 – 31/12/2015 | 9.8 mio. EUR | 9.1 mio. EUR | 175 mio. EUR | 90.3 mio. EUR | - | |
| 201401/01/2014 – 31/12/2014 | 11.4 mio. EUR | 6.2 mio. EUR | 158.4 mio. EUR | 60.4 mio. EUR | - | |
| 201301/01/2013 – 31/12/2013 | 11.9 mio. EUR | 6.2 mio. EUR | 89.9 mio. EUR | 55.8 mio. EUR | - |
Compared to 514 companies in Ikke-finansielle hovedsæders aktiviteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of ORIFARM GROUP A/S is 27347282.
ORIFARM GROUP A/S is owned by Orifarm Holding A/S.
The management of ORIFARM GROUP A/S consists of Mads Fink Eriksen and Thomas Brandhof.
The board of ORIFARM GROUP A/S consists of Hans Carl Bøgh-Sørensen, Ole Michael Friis and Adeel Ahmad, with Hans Carl Bøgh-Sørensen as chair.
In 2025, ORIFARM GROUP A/S reported a gross profit of EUR 1,478,000.
ORIFARM GROUP A/S had 62 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 63952700 (May 26, 2026).
As of May 20, 2026, Claudio Albrecht has left the board of directors of ORIFARM GROUP A/S.
Contact info changed: new phone: 63952700 (May 1, 2026).
As of May 1, 2026, Pierre Richard Bourdage has joined the board of directors of ORIFARM GROUP A/S.
Contact info changed: new phone: 63952700 (April 16, 2026).
ORIFARM GROUP A/S has published its annual report for 2025. Revenue came to DKK 0, and the net result was DKK 51,761,000.
As of March 3, 2026, Jeffrey Martin Rope has left the board of directors of ORIFARM GROUP A/S.
As of November 1, 2025, Sébastien Roche has joined the board of directors of ORIFARM GROUP A/S.
As of May 27, 2025, Anders Hagh has left the board of directors of ORIFARM GROUP A/S.
As of April 8, 2025, Orifarm Holding A/S is registered as an owner of ORIFARM GROUP A/S with an ownership share of 100%.
ORIFARM GROUP A/S has published its annual report for 2024. Revenue came to DKK 3,791,000, and the net result was DKK 3,260,000.
As of March 17, 2025, Thomas Brandhof is registered as director of ORIFARM GROUP A/S.
As of March 17, 2025, Mads Fink Eriksen is registered as adm. dir. of ORIFARM GROUP A/S.
As of March 17, 2025, Erik Sandberg has stepped down as adm. dir. of ORIFARM GROUP A/S.
As of March 16, 2025, Mads Fink Eriksen has stepped down as director of ORIFARM GROUP A/S.
As of January 24, 2025, Adeel Ahmad has joined the board of directors of ORIFARM GROUP A/S.
As of January 24, 2025, Nicola Falcinelli has joined the board of directors of ORIFARM GROUP A/S.
As of October 1, 2024, Mads Fink Eriksen is registered as director of ORIFARM GROUP A/S.
As of October 1, 2024, Jacob Lucassen has stepped down as director of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2023. Revenue came to DKK 3,664,000, and the net result was DKK 22,442,000.
As of April 23, 2024, Stine Schmidt Magnussen has joined the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Lotte Stenkjær Fletcher has joined the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Malene Segnitz Brøndum has joined the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Søren Møller Hansen has left the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Jens Christian Greve has left the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Mette Bille Rasmussen has left the board of directors of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2022. Revenue came to DKK 3,437,000, and the net result was DKK 27,404,000.
ORIFARM GROUP A/S has published its annual report for 2021. Revenue came to DKK 1,361,000, and the net result was DKK 28,690,000.
As of June 21, 2021, Jeffrey Martin Rope has joined the board of directors of ORIFARM GROUP A/S.
As of May 20, 2021, Heidi Wase Skovhus has joined the board of directors of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2020. Revenue came to DKK 8,627,000, and the net result was DKK 25,518,000.
As of August 21, 2020, Hans Carl Bøgh-Sørensen has joined the board of directors of ORIFARM GROUP A/S.
As of August 21, 2020, Niels Harald de Coninck-Smith has left the board of directors of ORIFARM GROUP A/S.
As of August 20, 2020, Hans Carl Bøgh-Sørensen has left the board of directors of ORIFARM GROUP A/S.
As of August 13, 2020, Anders Hagh has joined the board of directors of ORIFARM GROUP A/S.
As of June 29, 2020, Lars Monrad-Gylling has left the board of directors of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2019. Revenue came to DKK 13,878,000, and the net result was DKK 34,737,000.
As of March 16, 2020, Søren Møller Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of March 16, 2020, Jens Christian Greve has joined the board of directors of ORIFARM GROUP A/S.
As of March 16, 2020, Mette Bille Rasmussen has joined the board of directors of ORIFARM GROUP A/S.
As of March 16, 2020, Karsten Dybmose Truelsen has left the board of directors of ORIFARM GROUP A/S.
As of March 16, 2020, Christian Frederik Gyde Hansen has left the board of directors of ORIFARM GROUP A/S.
As of March 16, 2020, Søren Slott Sørensen has left the board of directors of ORIFARM GROUP A/S.
As of March 10, 2020, Eva Berner has stepped down as director of ORIFARM GROUP A/S.
As of August 26, 2019, Karsten Dybmose Truelsen has joined the board of directors of ORIFARM GROUP A/S.
As of August 26, 2019, Bettina Britt Juel Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of August 26, 2019, Dan Kyster Hartwig has left the board of directors of ORIFARM GROUP A/S.
As of August 25, 2019, Bettina Britt Juel Hansen has left the board of directors of ORIFARM GROUP A/S.
As of August 16, 2019, Karen Lykke Sørensen has left the board of directors of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2018. Revenue came to DKK 10,016,000, and the net result was DKK 26,454,000.
As of December 20, 2018, Hans Carl Bøgh-Sørensen has joined the board of directors of ORIFARM GROUP A/S.
As of December 20, 2018, Peter Arend William Burema has left the board of directors of ORIFARM GROUP A/S.
As of December 20, 2018, Erik Sandberg is registered as adm. dir. of ORIFARM GROUP A/S.
As of December 20, 2018, Hans Carl Bøgh-Sørensen has stepped down as adm. dir. of ORIFARM GROUP A/S.
As of December 19, 2018, Erik Sandberg has stepped down as director of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2017. Revenue came to DKK 8,611,000, and the net result was DKK 21,881,000.
As of May 15, 2018, Eva Berner is registered as director of ORIFARM GROUP A/S.
As of May 15, 2018, Ulrik Ernst Rasmussen has stepped down as director of ORIFARM GROUP A/S.
As of February 21, 2018, Karen Lykke Sørensen has joined the board of directors of ORIFARM GROUP A/S.
As of July 31, 2017, Frank Dirk Nauert has left the board of directors of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2016. Revenue came to DKK 8,786,000, and the net result was DKK 10,181,000.
As of November 1, 2016, Ulrik Ernst Rasmussen is registered as director of ORIFARM GROUP A/S.
As of November 1, 2016, Jacob Lucassen is registered as director of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2015. Revenue came to DKK 9,826,000, and the net result was DKK 9,120,000.
As of May 31, 2016, Jeanette Jæger Wallentin has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Christian Frederik Gyde Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Dan Kyster Hartwig has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Bettina Britt Juel Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Søren Slott Sørensen has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Søren Larsen has left the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Karsten Dybmose Truelsen has left the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Ane Kirstine Schmidt has left the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Rikke Klitgaard Hermann has left the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Maria Lefevre Borch has left the board of directors of ORIFARM GROUP A/S.
As of August 27, 2015, Frank Dirk Nauert has joined the board of directors of ORIFARM GROUP A/S.
As of August 27, 2015, Claus Christian Bayer has left the board of directors of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2014. Revenue came to DKK 11,395,000, and the net result was DKK 6,229,000.
ORIFARM GROUP A/S has published its annual report for 2013. Revenue came to DKK 11,928,000, and the net result was DKK 6,225,000.
As of May 20, 2014, Lars Monrad-Gylling has joined the board of directors of ORIFARM GROUP A/S.
As of May 20, 2014, Claudio Albrecht has joined the board of directors of ORIFARM GROUP A/S.
As of May 20, 2014, Carsten Fode has left the board of directors of ORIFARM GROUP A/S.
As of April 8, 2014, Søren Larsen has joined the board of directors of ORIFARM GROUP A/S.
As of April 8, 2014, Maria Lefevre Borch has joined the board of directors of ORIFARM GROUP A/S.
As of April 8, 2014, Hans Christian Eberhard Groth Teisen has stepped down as økonomidirektør of ORIFARM GROUP A/S.
As of April 8, 2014, Peter Raupach Linnet has stepped down as director of ORIFARM GROUP A/S.
As of January 1, 2014, Karsten Dybmose Truelsen has joined the board of directors of ORIFARM GROUP A/S.
As of January 1, 2014, Karsten Dybmose Truelsen has left the board of directors of ORIFARM GROUP A/S.
As of January 1, 2014, Martin Christian Hansen has left the board of directors of ORIFARM GROUP A/S.
As of January 1, 2014, Christian Lindberg Bundgaard has left the board of directors of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2012.
As of May 31, 2013, Frank Dirk Nauert has stepped down as director of ORIFARM GROUP A/S.
As of December 21, 2012, Jan Kruse Hansen has stepped down as director of ORIFARM GROUP A/S.
As of July 5, 2012, Hans Christian Eberhard Groth Teisen is registered as økonomidirektør of ORIFARM GROUP A/S.
As of July 5, 2012, Ole Ibsen has stepped down as økonomidirektør of ORIFARM GROUP A/S.
As of May 25, 2012, Karsten Dybmose Truelsen has joined the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Martin Christian Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Ane Kirstine Schmidt has joined the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Rikke Klitgaard Hermann has joined the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Christian Lindberg Bundgaard has joined the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Kjeld Hansen has left the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Karsten Dybmose Truelsen has left the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Vivi Reuss has left the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Jacob Velling Bower has left the board of directors of ORIFARM GROUP A/S.
As of May 25, 2012, Kim Ottosen has left the board of directors of ORIFARM GROUP A/S.
As of April 26, 2012, Erik Sandberg is registered as director of ORIFARM GROUP A/S.
As of April 19, 2012, Kenneth Egelund Schmidt has left the board of directors of ORIFARM GROUP A/S.
As of February 10, 2012, Kenneth Egelund Schmidt has joined the board of directors of ORIFARM GROUP A/S.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ORIFARM GROUP A/S.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of ORIFARM GROUP A/S.
As of May 26, 2010, Niels Harald de Coninck-Smith has joined the board of directors of ORIFARM GROUP A/S.
As of May 26, 2010, Peter Arend William Burema has joined the board of directors of ORIFARM GROUP A/S.
As of May 26, 2010, Villy Rasmussen has left the board of directors of ORIFARM GROUP A/S.
As of May 26, 2010, Claudio Albrecht has left the board of directors of ORIFARM GROUP A/S.
As of November 24, 2009, Claudio Albrecht has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2009, Christen Højgaard Nielsen has left the board of directors of ORIFARM GROUP A/S.
As of March 24, 2009, Peter Raupach Linnet is registered as director of ORIFARM GROUP A/S.
As of March 24, 2009, Jan Kruse Hansen is registered as director of ORIFARM GROUP A/S.
As of May 29, 2008, Ole Michael Friis has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2008, Kjeld Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2008, Villy Rasmussen has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2008, Vivi Reuss has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2008, Jacob Velling Bower has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2008, Kim Ottosen has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2008, Jørgen Olander Strandbæk has left the board of directors of ORIFARM GROUP A/S.
As of May 29, 2008, Dorte Bjerg has left the board of directors of ORIFARM GROUP A/S.
As of April 15, 2008, Ole Ibsen is registered as økonomidirektør of ORIFARM GROUP A/S.
As of April 14, 2008, Per Munk Laustsen has stepped down as director of ORIFARM GROUP A/S.
As of May 23, 2007, Claus Christian Bayer has joined the board of directors of ORIFARM GROUP A/S.
As of May 23, 2007, Niels Harald de Coninck-Smith has left the board of directors of ORIFARM GROUP A/S.
As of May 23, 2007, John Morell Frellsen has stepped down as director of ORIFARM GROUP A/S.
On April 30, 2007, the company changed its name from CAREFARM A/S to ORIFARM GROUP A/S.
As of August 31, 2006, Ragnhild Birgitte Jensen has stepped down as director of ORIFARM GROUP A/S.
As of June 19, 2006, Carsten Fode has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2006, Niels Harald de Coninck-Smith has joined the board of directors of ORIFARM GROUP A/S.
As of May 29, 2006, Tommy Vestergaard Christiansen has left the board of directors of ORIFARM GROUP A/S.
As of May 29, 2006, Jan Johannes Wøidemann has left the board of directors of ORIFARM GROUP A/S.
As of May 29, 2006, John Morell Frellsen has left the board of directors of ORIFARM GROUP A/S.
As of May 24, 2006, Jørgen Olander Strandbæk has joined the board of directors of ORIFARM GROUP A/S.
As of May 24, 2006, Dorte Bjerg has joined the board of directors of ORIFARM GROUP A/S.
As of January 16, 2006, Per Kongsdal Rasmussen has left the board of directors of ORIFARM GROUP A/S.
As of December 22, 2005, Frank Dirk Nauert is registered as director of ORIFARM GROUP A/S.
As of April 21, 2005, Per Kongsdal Rasmussen has joined the board of directors of ORIFARM GROUP A/S.
As of April 21, 2005, Robert Mølgaard Larsen has left the board of directors of ORIFARM GROUP A/S.
As of April 21, 2005, Per Kongsdal Rasmussen has left the board of directors of ORIFARM GROUP A/S.
As of December 20, 2004, Hans Carl Bøgh-Sørensen is registered as adm. dir. of ORIFARM GROUP A/S.
As of December 10, 2004, John Morell Frellsen is registered as director of ORIFARM GROUP A/S.
As of June 25, 2004, Karsten Dybmose Truelsen has joined the board of directors of ORIFARM GROUP A/S.
As of June 25, 2004, John Morell Frellsen has joined the board of directors of ORIFARM GROUP A/S.
As of June 25, 2004, Gitte Alhed Poulsen has joined the board of directors of ORIFARM GROUP A/S.
As of April 30, 2004, Robert Mølgaard Larsen has joined the board of directors of ORIFARM GROUP A/S.
As of April 30, 2004, Per Kongsdal Rasmussen has joined the board of directors of ORIFARM GROUP A/S.
As of September 22, 2003, Ragnhild Birgitte Jensen is registered as director of ORIFARM GROUP A/S.
As of September 12, 2003, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of ORIFARM GROUP A/S.
As of September 12, 2003, Tommy Vestergaard Christiansen has joined the board of directors of ORIFARM GROUP A/S.
As of September 12, 2003, Jan Johannes Wøidemann has joined the board of directors of ORIFARM GROUP A/S.
As of September 12, 2003, Christen Højgaard Nielsen has joined the board of directors of ORIFARM GROUP A/S.
As of September 12, 2003, Per Munk Laustsen is registered as director of ORIFARM GROUP A/S.
As of September 12, 2003, Birgitte Bøgh-Sørensen is registered as director of ORIFARM GROUP A/S.
As of September 12, 2003, Birgitte Bøgh-Sørensen has stepped down as director of ORIFARM GROUP A/S.
ORIFARM GROUP A/S was founded on September 12, 2003.
Companies in the same industry and area
CVR 46335511
CVR 45784622
CVR 84299510
CVR 27471870
CVR 53777813
